These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33882330)

  • 1. IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapy.
    Gutzmer R; Sibaud V; Hassel JC
    Ann Oncol; 2021 Jun; 32(6):696-697. PubMed ID: 33882330
    [No Abstract]   [Full Text] [Related]  

  • 2. IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies.
    Barrios DM; Phillips GS; Geisler AN; Trelles SR; Markova A; Noor SJ; Quigley EA; Haliasos HC; Moy AP; Schram AM; Bromberg J; Funt SA; Voss MH; Drilon A; Hellmann MD; Comen EA; Narala S; Patel AB; Wetzel M; Jung JY; Leung DYM; Lacouture ME
    Ann Oncol; 2021 Jun; 32(6):736-745. PubMed ID: 33667669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of omalizumab in Cutaneous Mastocytosis: A case series.
    Hinojosa T; Lewis DJ; Vangipuram R; Safeer L; Mui UN; Haley C; Konoplev S; Tyring SK
    Dermatol Ther; 2019 May; 32(3):e12848. PubMed ID: 30697883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Omalizumab in Patients with Chronic Spontaneous Urticaria and Its Association with Serum IgE Levels and Eosinophil Count.
    Tamer F; Gulru Erdogan F; Dincer Rota D; Yildirim D; Akpinar Kara Y
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):101-106. PubMed ID: 31351504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study.
    Kallieri M; Papaioannou AI; Papathanasiou E; Ntontsi P; Papiris S; Loukides S
    Postgrad Med; 2017 Aug; 129(6):598-604. PubMed ID: 28427296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders.
    Foroughi S; Foster B; Kim N; Bernardino LB; Scott LM; Hamilton RG; Metcalfe DD; Mannon PJ; Prussin C
    J Allergy Clin Immunol; 2007 Sep; 120(3):594-601. PubMed ID: 17765756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
    Humbert M; Taillé C; Mala L; Le Gros V; Just J; Molimard M;
    Eur Respir J; 2018 May; 51(5):. PubMed ID: 29545284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab for the treatment of atopic dermatitis.
    Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
    Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma.
    Kupryś-Lipińska I; Molińska K; Kuna P
    Pneumonol Alergol Pol; 2016; 84(4):232-43. PubMed ID: 27435350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab in the Therapy of Pediatric Asthma.
    Poddighe D; Brambilla I; Licari A; Marseglia GL
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):103-109. PubMed ID: 29714140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omalizumab alleviates pruritus in myeloproliferative neoplasms.
    Ravn Landtblom A; Ungerstedt J; Hedlund A; Tobiasson M; Deneberg S; Jädersten M
    Haematologica; 2023 Jul; 108(7):1968-1971. PubMed ID: 36700402
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of omalizumab on nasal allergic inflammation.
    Plewako H; Arvidsson M; Petruson K; Oancea I; Holmberg K; Adelroth E; Gustafsson H; Sandström T; Rak S
    J Allergy Clin Immunol; 2002 Jul; 110(1):68-71. PubMed ID: 12110823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients.
    Alamon-Reig F; Bosch-Amate X; Giavedoni P; Nikolaou V; Mangas C; Apalla Z; Mayor A; Oikonomou C; Starace M; Sibaud V; Carrera C
    J Am Acad Dermatol; 2024 Feb; 90(2):429-432. PubMed ID: 37844688
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinergic pruritus responding to omalizumab.
    Hasan SB; Ali FM; Ingram JR
    Clin Exp Dermatol; 2020 Mar; 45(2):264-266. PubMed ID: 31323131
    [No Abstract]   [Full Text] [Related]  

  • 15. Omalizumab for the management of refractory aquagenic pruritus.
    Koumaki D; Gregoriou S; Katoulis A; Evangelou G
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):e1316-e1317. PubMed ID: 37415343
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study of omalizumab in eosinophilic esophagitis.
    Loizou D; Enav B; Komlodi-Pasztor E; Hider P; Kim-Chang J; Noonan L; Taber T; Kaushal S; Limgala R; Brown M; Gupta R; Balba N; Goker-Alpan O; Khojah A; Alpan O
    PLoS One; 2015; 10(3):e0113483. PubMed ID: 25789989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective.
    Caminati M; Vianello A; Chieco Bianchi F; Festi G; Guarnieri G; Marchi MR; Micheletto C; Olivieri M; Tognella S; Guerriero M; Senna G;
    J Investig Allergol Clin Immunol; 2020; 30(1):35-41. PubMed ID: 30676321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid.
    Seyed Jafari SM; Gadaldi K; Feldmeyer L; Yawalkar N; Borradori L; Schlapbach C
    Front Immunol; 2019; 10():1919. PubMed ID: 31474990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
    Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV
    Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IgE treatment in allergic rhinitis.
    Bayar Muluk N; Bafaqeeh SA; Cingi C
    Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109674. PubMed ID: 31526939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.